Literature DB >> 17146309

Resistance training and reduction of treatment side effects in prostate cancer patients.

Daniel A Galvão1, Kazunori Nosaka, Dennis R Taaffe, Nigel Spry, Linda J Kristjanson, Michael R McGuigan, Katsuhiko Suzuki, Kanemitsu Yamaya, Robert U Newton.   

Abstract

PURPOSE: To examine the effect of progressive resistance training on muscle function, functional performance, balance, body composition, and muscle thickness in men receiving androgen deprivation for prostate cancer.
METHODS: Ten men aged 59-82 yr on androgen deprivation for localized prostate cancer undertook progressive resistance training for 20 wk at 6- to 12-repetition maximum (RM) for 12 upper- and lower-body exercises in a university exercise rehabilitation clinic. Outcome measures included muscle strength and muscle endurance for the upper and lower body, functional performance (repeated chair rise, usual and fast 6-m walk, 6-m backwards walk, stair climb, and 400-m walk time), and balance by sensory organization test. Body composition was measured by dual-energy x-ray absorptiometry and muscle thickness at four anatomical sites by B-mode ultrasound. Blood samples were assessed for prostate specific antigen (PSA), testosterone, growth hormone (GH), cortisol, and hemoglobin.
RESULTS: Muscle strength (chest press, 40.5%; seated row, 41.9%; leg press, 96.3%; P < 0.001) and muscle endurance (chest press, 114.9%; leg press, 167.1%; P < 0.001) increased significantly after training. Significant improvement (P < 0.05) occurred in the 6-m usual walk (14.1%), 6-m backwards walk (22.3%), chair rise (26.8%), stair climbing (10.4%), 400-m walk (7.4%), and balance (7.8%). Muscle thickness increased (P < 0.05) by 15.7% at the quadriceps site. Whole-body lean mass was preserved with no change in fat mass. There were no significant changes in PSA, testosterone, GH, cortisol, or hemoglobin.
CONCLUSIONS: Progressive resistance exercise has beneficial effects on muscle strength, functional performance and balance in older men receiving androgen deprivation for prostate cancer and should be considered to preserve body composition and reduce treatment side effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17146309     DOI: 10.1249/01.mss.0000233803.48691.8b

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  95 in total

Review 1.  A review of exercise interventions to improve bone health in adult cancer survivors.

Authors:  Kerri M Winters-Stone; Anna Schwartz; Lillian M Nail
Journal:  J Cancer Surviv       Date:  2010-04-07       Impact factor: 4.442

Review 2.  The effects of resistance training on quality of life in cancer: a systematic literature review and meta-analysis.

Authors:  Fiona Cramp; Abigail James; Jessica Lambert
Journal:  Support Care Cancer       Date:  2010-05-26       Impact factor: 3.603

3.  Disparities in Health Risk Behavior and Psychological Distress Among Gay Versus Heterosexual Male Cancer Survivors.

Authors:  Charles Kamen; Oxana Palesh; Arianna Aldridge Gerry; Michael A Andrykowski; Charles Heckler; Supriya Mohile; Gary R Morrow; Deborah Bowen; Karen Mustian
Journal:  LGBT Health       Date:  2013-11-26       Impact factor: 4.151

Review 4.  A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants.

Authors:  Lene Thorsen; Kerry S Courneya; Clare Stevinson; Sophie D Fosså
Journal:  Support Care Cancer       Date:  2008-02-15       Impact factor: 3.603

Review 5.  A framework for assessment in oncology rehabilitation.

Authors:  Laura S Gilchrist; Mary Lou Galantino; Meredith Wampler; Victoria G Marchese; G Stephen Morris; Kirsten K Ness
Journal:  Phys Ther       Date:  2009-01-15

6.  A randomised controlled trial to evaluate the efficacy of a 6-month dietary and physical activity intervention for patients receiving androgen deprivation therapy for prostate cancer.

Authors:  Roisin F O'Neill; Farhana Haseen; Liam J Murray; Joe M O'Sullivan; Marie M Cantwell
Journal:  J Cancer Surviv       Date:  2015-04-28       Impact factor: 4.442

Review 7.  Management of complications of androgen deprivation therapy in the older man.

Authors:  Supriya G Mohile; Karen Mustian; Kathryn Bylow; William Hall; William Dale
Journal:  Crit Rev Oncol Hematol       Date:  2008-10-25       Impact factor: 6.312

Review 8.  The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis.

Authors:  Ashley Bigaran; Eva Zopf; Jason Gardner; Andre La Gerche; Declan G Murphy; Erin J Howden; Michael K Baker; Prue Cormie
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-08-28       Impact factor: 5.554

Review 9.  Enhancing active surveillance of prostate cancer: the potential of exercise medicine.

Authors:  Daniel A Galvão; Dennis R Taaffe; Nigel Spry; Robert A Gardiner; Renea Taylor; Gail P Risbridger; Mark Frydenberg; Michelle Hill; Suzanne K Chambers; Phillip Stricker; Tom Shannon; Dickon Hayne; Eva Zopf; Robert U Newton
Journal:  Nat Rev Urol       Date:  2016-03-08       Impact factor: 14.432

10.  Physical activity for men receiving androgen deprivation therapy for prostate cancer: benefits from a 16-week intervention.

Authors:  S Nicole Culos-Reed; John W Robinson; Harold Lau; Lynette Stephenson; Melanie Keats; Steve Norris; Greg Kline; Peter Faris
Journal:  Support Care Cancer       Date:  2009-07-16       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.